F773 in Pennsylvania. Pick another state for the same tag.
Against expectation — 2025
Pennsylvania cites F773 more often than its own record predicts
Versus expected share1.62×
1.62 times the share F773 takes of citations nationally.
Share of Pennsylvania citations0.21%
Of every deficiency written in Pennsylvania in 2025, this is the portion that was F773.
Pennsylvania0.21%
National0.13%
Share of all citations that were F773.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Pennsylvania surveyors wrote
F773 findings written in Pennsylvania, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
G · Actual harm, isolatedAugust 3, 2021
Based on clinical record review and staff interview it was determined that the facility failed to promptly notify the physician of an elevated PT (Prothrombin time test which is a test to evaluate blood clotting; an elevated number higher than range means it takes longer than usual to clot) with PT INR [(international normalized ratio; a type of calculation based on PT test results; often used to see how well [MEDICATION(S)] (an anticoagulant medication) is working] laboratory result, which resulted in the resident continuing to receive the same dosage of [MEDICATION(S)], causing [MEDICATION(S)] toxicity and GI bleed requiring hospitalization for one of three sampled residents (Resident A1). …
D · No harm, potential for more than minimal, isolatedApril 30, 2026
Based on review of policies and clinical records, as well as staff interviews, it was determined that the facility failed to notify the physician of laboratory test results for one of 44 residents reviewed (Resident 123).Findings include: The facility policy for laboratory tests, dated February 27, 2016, indicated that the physician would be notified immediately if a test was obtained to monitor the blood level of a medication and the level was reported as high (above therapeutic range) or toxic, the nurse will notify the physician promptly and will not give the next dose until the situation has been reviewed with the physician.An admission Minimum Data Set (MDS) assessment (a mandated assessment of a resident's care needs and abilities) for Resident 123, dated February 24, 2026, revealed… …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction